中文名：Infliximab (anti-TNF-alpha)
英文名：Infliximab (anti-TNF-alpha)
中文別名：Infliximab; Remicade; Remsima; Inflectra; Avakine; CT-P13; 英夫利昔單抗; APC1 antibody; APC1 protein antibody; Cachectin antibody; DIF antibody; Differentiation inducing factor antibody; Macrophage cytotoxic factor antibody; Tnf antibody; TNF superfamily member
英文別名：Infliximab; Remicade; Remsima; Inflectra; Avakine; CT-P13; APC1 antibody; APC1 protein antibody; Cachectin antibody; DIF antibody; Differentiation inducing factor antibody; Macrophage cytotoxic factor antibody; Tnf antibody; TNF superfamily member 2 antib
純度：Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
貨號(hào)：I412009
包裝：5mg、10mg、1mg
Cas號(hào)：170277-31-3
存儲(chǔ)溫度：-80℃儲(chǔ)存,避免反復(fù)凍融
產(chǎn)品介紹：
Infliximab (anti-TNF-alpha) 是一種與TNF-α特異性結(jié)合的嵌合單克隆IgG1抗體,可阻止TNF-α與TNF-α受體(TNFR1和TNFR2)的相互作用，用于治療克羅恩病和類風(fēng)濕性關(guān)節(jié)炎。
查看阿拉丁官網(wǎng)此產(chǎn)品相關(guān)對(duì)應(yīng)頁(yè)面：https://www.aladdin-e.com/zh_cn/I412009.html
關(guān)鍵字： Infliximab; Remicade; Remsima; Inflectra; Avakine; CT-P13; 英夫利昔單抗; APC1 antibody; APC1 protein antibody; Cachectin antibody; DIF antibody; Differentiation inducing factor antibody; Macrophage cytotoxic factor antibody; Tnf antibody; TNF superfamily member;Infliximab; Remicade; Remsima; Inflectra; Avakine; CT-P13; APC1 antibody; APC1 protein antibody; Cachectin antibody; DIF antibody; Differentiation inducing factor antibody; Macrophage cytotoxic factor antibody; Tnf antibody; TNF superfamily member 2 antib
上海阿拉丁生化科技股份有限公司是A股上市公司（（股票代碼：688179），專注于科研試劑的研發(fā)、生產(chǎn)和銷售，已陸續(xù)建立多個(gè)工廠和研發(fā)中心。作為領(lǐng)軍企業(yè)，阿拉丁始終堅(jiān)持質(zhì)量第一，連續(xù)13年被評(píng)為“最受歡迎試劑品牌”。
阿拉丁目前常備庫(kù)存試劑產(chǎn)品品種超過(guò)7萬(wàn)種，SKU總數(shù)超過(guò)46萬(wàn)，產(chǎn)品線涵蓋了化學(xué)試劑、生化試劑、藥靶配體、蛋白質(zhì)和抗體等多個(gè)領(lǐng)域，是國(guó)內(nèi)少數(shù)化學(xué)試劑到生物試劑全面發(fā)展的國(guó)產(chǎn)試劑品牌，產(chǎn)品同步發(fā)布在我們國(guó)內(nèi)外電商平臺(tái)。